Many grandparents’ medicines aren’t secure enough around grandchildren, according to the National Poll on Healthy Aging.

Hesitation to put MS patients on the operating table, due to relapse risk, may have physicians delaying important surgeries unnecessarily.

Success of phase 3 trial evaluating teprotumumab for treatment of active thyroid eye disease (TED) brings drug closer to FDA approval.

As health care providers push to reduce low-value care, they should put more emphasis on assessing unintended consequences, listening to patients and providers, and measuring outcomes, a U-M-led review finds.

A new study finds there’s excessive imaging testing being performed in the emergency department. A reduction could save millions in health care costs.

A study in rats has revealed the presence of naturally occurring dimethyltryptamine (DMT), an increasingly popular hallucinogen.

A new website is helping patients with scleroderma learn more about the condition, how to manage their symptoms and self-advocacy strategies.

Seeking medical treatment can be stressful, confusing and even dangerous with a language barrier. U-M’s interpreter services team strives to bridge the gap, despite recent political challenges.

Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

For victims of gun violence and veterans of war who have post-traumatic stress disorder, the Fourth of July holiday can be a stressful time of year.

A U-M otolaryngology team has designed an innovative trach plug for patients who either no longer need a tracheostomy tube or require support only intermittently.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

American Heart Association funding will allow Michigan Medicine to establish a leading research and training program with a focus on preventing brain damage caused by out-of-hospital cardiac arrest.

A new tool “scores” patients based on the impact of their multiple chronic conditions. The tool reveals that those with higher scores have faster memory loss, a higher suicide risk and a higher overall risk of death.

Runge’s new term was approved by the board of regents and will last from July 1 until June 30, 2025.